210 related articles for article (PubMed ID: 28821383)
1. Omalizumab for hypersensitive reaction to seminal plasma: A case report.
Burguete-Cabanas MT; Fajardo-Ramirez OR; Yesaki R; Estrada-Maganas R; Salazar-Meza S; Rios-Chavez O; Meester I; Salas-Alanis JC
Allergol Int; 2018 Apr; 67(2):278-279. PubMed ID: 28821383
[No Abstract] [Full Text] [Related]
2. Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab.
Heffler E; Fichera S; Nicolosi G; Crimi N
J Allergy Clin Immunol Pract; 2017; 5(3):852-854. PubMed ID: 28258855
[No Abstract] [Full Text] [Related]
3. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C.
Leiva-Salinas M; Francés L; Marin-Cabanas I; Arribas Granados MP; Silvestre JF
J Eur Acad Dermatol Venereol; 2015 May; 29(5):1027-8. PubMed ID: 24629127
[No Abstract] [Full Text] [Related]
5. Omalizumab, a savior in long term prevention of idiopathic anaphylaxis with urticaria: A case series.
Singh GK
Dermatol Ther; 2021 Nov; 34(6):e15165. PubMed ID: 34676646
[No Abstract] [Full Text] [Related]
6. Real-life treatment of cholinergic urticaria with omalizumab.
Altrichter S; Chuamanochan M; Knoth H; Asady A; Ohanyan T; Metz M; Maurer M
J Allergy Clin Immunol; 2019 Feb; 143(2):788-791.e8. PubMed ID: 30312709
[No Abstract] [Full Text] [Related]
7. Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.
Gericke J; Metz M; Ohanyan T; Weller K; Altrichter S; Skov PS; Falkencrone S; Brand J; Kromminga A; Hawro T; Church MK; Maurer M
J Allergy Clin Immunol; 2017 Mar; 139(3):1059-1061.e1. PubMed ID: 27838346
[No Abstract] [Full Text] [Related]
8. Effectiveness of omalizumab in severe solar urticaria.
de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538
[No Abstract] [Full Text] [Related]
9. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest.
Combalia A; Fernández-Sartorio C; Aguilera P
Actas Dermosifiliogr; 2017; 108(6):593-594. PubMed ID: 28168968
[No Abstract] [Full Text] [Related]
10. Omalizumab-induced triphasic anaphylaxis in a patient with chronic spontaneous urticaria.
Gönül M; Özenergün Bittacı A; Ergin C
J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e135-e136. PubMed ID: 26446412
[No Abstract] [Full Text] [Related]
11. Successful treatment of refractory cholinergic urticaria with omalizumab.
Koumaki D; Seaton ED
Int J Dermatol; 2018 Jan; 57(1):114. PubMed ID: 29057464
[No Abstract] [Full Text] [Related]
12. Solar urticaria treated with omalizumab.
Schaffenburg WC; Guerrero KT; Marks SN
Cutis; 2019 Jul; 104(1):E4-E5. PubMed ID: 31487346
[No Abstract] [Full Text] [Related]
13. Treatment with omalizumab or cyclosporine for resistant chronic spontaneous urticaria.
Koski R; Kennedy KK
Ann Allergy Asthma Immunol; 2017 Nov; 119(5):397-401. PubMed ID: 29150066
[No Abstract] [Full Text] [Related]
14. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
Geller M
Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
[No Abstract] [Full Text] [Related]
15. Urticaria, Angioedema, and Anaphylaxis.
Pier J; Bingemann TA
Pediatr Rev; 2020 Jun; 41(6):283-292. PubMed ID: 32482691
[TBL] [Abstract][Full Text] [Related]
16. Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria.
Ertas R; Ozyurt K; Ozlu E; Ulas Y; Avci A; Atasoy M; Hawro T; Maurer M
J Allergy Clin Immunol; 2017 Dec; 140(6):1749-1751. PubMed ID: 28870460
[No Abstract] [Full Text] [Related]
17. Successful treatment with omalizumab in challenge confirmed exercise-induced anaphylaxis.
Christensen MJ; Bindslev-Jensen C
J Allergy Clin Immunol Pract; 2017; 5(1):204-206. PubMed ID: 27839749
[No Abstract] [Full Text] [Related]
18. Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial.
Metz M; Schütz A; Weller K; Gorczyza M; Zimmer S; Staubach P; Merk HF; Maurer M
J Allergy Clin Immunol; 2017 Sep; 140(3):864-867.e5. PubMed ID: 28389393
[No Abstract] [Full Text] [Related]
19. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
Kaplan AP; Giménez-Arnau AM; Saini SS
Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
[TBL] [Abstract][Full Text] [Related]
20. Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.
Saini SS; Omachi TA; Trzaskoma B; Hulter HN; Rosén K; Sterba PM; Courneya JP; Lackey A; Chen H
J Invest Dermatol; 2017 Apr; 137(4):958-961. PubMed ID: 27939380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
